Cargando…
Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy
INTRODUCTION: Self-limited infantile epilepsy (SeLIE) is a benign epilepsy. Previous studies have shown that monotherapy with most antiseizure medications can effectively relieve seizures in patients with SeLIE, but the efficacy of levetiracetam has not been investigated. OBJECTIVE: This study aimed...
Autores principales: | Tian, Yang, Shi, Zhen, Cai, Jiahao, Hou, Chi, Wang, Xiuying, Zhu, Haixia, Peng, Binwei, Shi, Kaili, Li, Xiaojing, Gong, Sitang, Chen, Wen-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601096/ https://www.ncbi.nlm.nih.gov/pubmed/37880614 http://dx.doi.org/10.1186/s12887-023-04212-w |
Ejemplares similares
-
Different experiences of two PRRT2-associated self-limited familial infantile epilepsy
por: Zhao, Qianlei, et al.
Publicado: (2020) -
Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis
por: Yang, Xiaoling, et al.
Publicado: (2013) -
PRRT2
‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers
por: Lee, Jiwon, et al.
Publicado: (2023) -
Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy
por: Döring, Jan H., et al.
Publicado: (2022) -
Clinical and genetic analysis of benign familial infantile epilepsy caused by PRRT2 gene variant
por: Gu, Yu, et al.
Publicado: (2023)